The Pharmacy and Poisons Board (PPB) would like to make a clarification on the reports circulating in the media about Duo-Cotecxin.
The Board would like to clarify that NO RECALL OR WITHDRAWAL is being conducted for the above product.
The Pharmacy and Poisons Board is undertaking investigations to ascertain the suspected quality defect on that specific batch No 160621. Meanwhile the batch is under quarantine pending conclusion of investigations.
We would like to assure all stakeholders that they shall be informed on the outcome of investigations once concluded.